Skip to main content
Premium Trial:

Request an Annual Quote

Shares in Decode Slide 7.7 Percent on Q4 Revenue Decline, Widened Loss

NEW YORK, March 7(GenomeWeb News) - Shares in Decode Genetics were down 7.74 percent, or $.73 at $8.70 in mid-afternoon trading after the company yesterday reported an approximately 13-percent decrease in revenues amid escalating losses for the fourth quarter.

 

As GenomeWeb News reported this morning, Decode's revenues for the three months ended Dec.31, 2005, dropped to $9.8 million from $11.2 million year over year, while losses grew to $21.1 million from $19.4 million in the year-ago period.